Inovio Pharmaceuticals has announced that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, demonstrating the potential for a ...
Tags: DNA Vaccine, MERS Virus
Inovio Pharmaceuticals has received a US patent covering SynCon vaccine for cervical dysplasias and cancers caused by human papillomavirus (HPV). The patent covers Inovio's synthetic consensus HPV antigens, DNA constructs and vaccines ...
Tags: Inovio Pharmaceuticals, SynCon vaccine, HPV